Literature for PPACK (S01.217 inhibitor)

(Topics flags: S Structure, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2017
1. Handley,L.D., Fuglestad,B., Stearns,K., Tonelli,M., Fenwick,R.B., Markwick,P.R. and Komives,E.A.
   NMR reveals a dynamic allosteric pathway in thrombin
   Sci Rep7, 39575-39575. PubMed  Europe PubMed DOI  S  I
2016
2. Palekar,R.U., Jallouk,A.P., Myerson,J.W., Pan,H. and Wickline,S.A.
   Inhibition of thrombin With PPACK-nanoparticles restores disrupted endothelial barriers and attenuates thrombotic risk in experimental atherosclerosis
   Arterioscler Thromb Vasc Biol36, 446-455. PubMed  Europe PubMed DOI  I
2013
3. Fuglestad,B., Gasper,P.M., McCammon,J.A., Markwick,P.R. and Komives,E.A.
   Correlated Motions and Residual Frustration in Thrombin
   J Phys Chem B117, 12857-12863. PubMed  Europe PubMed DOI  S  I
2011
4. Kroh,H.K., Panizzi,P., Tchaikovski,S., Baird,T.R., Wei,N., Krishnaswamy,S., Tans,G., Rosing,J., Furie,B., Furie,B.C. and Bock,P.E.
   Active site-labeled prothrombin inhibits prothrombinase in vitro and thrombosis in vivo
   J Biol Chem286, 23345-23356. PubMed  Europe PubMed DOI  I
2009
5. Kovach,I.M., Kelley,P., Eddy,C., Jordan,F. and Baykal,A.
   Proton bridging in the interactions of thrombin with small inhibitors
   Biochemistry48, 7296-7304. PubMed  Europe PubMed DOI  I
1997
6. Martin,P.D., Malkowski,M.G., Box,J., Esmon,C.T. and Edwards,B.F.
   New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK
   Structure5, 1681-1693. PubMed  Europe PubMed  S  I
1994
7. Vijayalakshmi,J., Padmanabhan,K.P., Mann,K.G. and Tulinsky,A.
   The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin
   Protein Sci3, 2254-2271. PubMed  Europe PubMed DOI  S  I
1992
8. Bode,W., Turk,D. and Karshikov,A.
   The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships
   Protein Sci1, 426-471. PubMed  Europe PubMed DOI  S  I
1990
9. [YEAR:15-5-1990]Greco,N.J., Tenner,T.E., Jr., Tandon,N.N. and Jamieson,G.A.
   PPACK-thrombin inhibits thrombin-induced platelet aggregation and cytoplasmic acidification but does not inhibit platelet shape change
   Blood75, 1989-1990. PubMed  Europe PubMed  I
1989
10. Bode,W., Mayr,I., Baumann,U., Huber,R., Stone,S.R. and Hofsteenge,J.
    The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment
    EMBO J8, 3467-3475. PubMed  Europe PubMed  S  I
1986
11. Sturzebecher,J., Sturzebecher,U. and Markwardt,F.
    Inhibition of batroxobin, a serine proteinase from Bothrops snake venom, by derivatives of benzamidine
    Toxicon24, 585-595. PubMed  Europe PubMed  I
1982
12. Silverberg,M. and Kaplan,A.P.
    Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII)
    Blood60, 64-70. PubMed  Europe PubMed  I
1979
13. Kettner,C. and Shaw,E.
    D-Phe-Pro-ArgCH2Cl - a selective affinity label for thrombin
    Thromb Res14, 969-973. PubMed  Europe PubMed  I